argenx SE
argenx SE ARGX.BR Peers
See (ARGX.BR) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ARGX.BR | $488.70 | -2.01% | 29.84B | 43.44 | $11.25 | N/A |
| UCB.BR | $156.65 | -1.07% | 29.77B | 28.59 | $5.48 | +0.89% |
| TUB.BR | $123.20 | N/A | 5.48B | 60.69 | $2.03 | +0.84% |
| GLPG.AS | $23.00 | +0.88% | 1.52B | -8.42 | -$2.73 | N/A |
| GTBP.PA | $280.50 | N/A | 626.73M | -4.10 | -$68.39 | N/A |
| PHARM.AS | $0.87 | -0.11% | 592.89M | -43.57 | -$0.02 | N/A |
| MEDCL.PA | $15.05 | -1.18% | 497.68M | -13.81 | -$1.09 | N/A |
| VLA.PA | $2.90 | -0.62% | 484.39M | -36.22 | -$0.08 | N/A |
| ABVX.PA | $5.50 | -2.48% | 348.80M | -1.96 | -$2.80 | N/A |
| IVA.PA | $3.24 | +1.41% | 312.62M | -1.05 | -$3.08 | N/A |
Stock Comparison
ARGX.BR vs UCB.BR Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, UCB.BR has a market cap of 29.77B. Regarding current trading prices, ARGX.BR is priced at $488.70, while UCB.BR trades at $156.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas UCB.BR's P/E ratio is 28.59. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to UCB.BR's ROE of +0.11%. Regarding short-term risk, ARGX.BR is more volatile compared to UCB.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs TUB.BR Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, TUB.BR has a market cap of 5.48B. Regarding current trading prices, ARGX.BR is priced at $488.70, while TUB.BR trades at $123.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas TUB.BR's P/E ratio is 60.69. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to TUB.BR's ROE of +0.05%. Regarding short-term risk, ARGX.BR is more volatile compared to TUB.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs GLPG.AS Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, GLPG.AS has a market cap of 1.52B. Regarding current trading prices, ARGX.BR is priced at $488.70, while GLPG.AS trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas GLPG.AS's P/E ratio is -8.42. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to GLPG.AS's ROE of -0.06%. Regarding short-term risk, ARGX.BR is less volatile compared to GLPG.AS. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs GTBP.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, GTBP.PA has a market cap of 626.73M. Regarding current trading prices, ARGX.BR is priced at $488.70, while GTBP.PA trades at $280.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas GTBP.PA's P/E ratio is -4.10. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to GTBP.PA's ROE of -4.68%. Regarding short-term risk, ARGX.BR is less volatile compared to GTBP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs PHARM.AS Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, PHARM.AS has a market cap of 592.89M. Regarding current trading prices, ARGX.BR is priced at $488.70, while PHARM.AS trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas PHARM.AS's P/E ratio is -43.57. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to PHARM.AS's ROE of -0.05%. Regarding short-term risk, ARGX.BR is more volatile compared to PHARM.AS. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs MEDCL.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, MEDCL.PA has a market cap of 497.68M. Regarding current trading prices, ARGX.BR is priced at $488.70, while MEDCL.PA trades at $15.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas MEDCL.PA's P/E ratio is -13.81. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to MEDCL.PA's ROE of +0.66%. Regarding short-term risk, ARGX.BR is more volatile compared to MEDCL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs VLA.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, VLA.PA has a market cap of 484.39M. Regarding current trading prices, ARGX.BR is priced at $488.70, while VLA.PA trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas VLA.PA's P/E ratio is -36.22. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to VLA.PA's ROE of -0.06%. Regarding short-term risk, ARGX.BR is more volatile compared to VLA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ABVX.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ABVX.PA has a market cap of 348.80M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ABVX.PA trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ABVX.PA's P/E ratio is -1.96. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ABVX.PA's ROE of -2.11%. Regarding short-term risk, ARGX.BR is more volatile compared to ABVX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs IVA.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, IVA.PA has a market cap of 312.62M. Regarding current trading prices, ARGX.BR is priced at $488.70, while IVA.PA trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas IVA.PA's P/E ratio is -1.05. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to IVA.PA's ROE of +1.98%. Regarding short-term risk, ARGX.BR is more volatile compared to IVA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs DBV.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, DBV.PA has a market cap of 265.78M. Regarding current trading prices, ARGX.BR is priced at $488.70, while DBV.PA trades at $1.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas DBV.PA's P/E ratio is -1.92. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to DBV.PA's ROE of -1.64%. Regarding short-term risk, ARGX.BR and DBV.PA have similar daily volatility (4.95).
ARGX.BR vs ORY.MC Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ORY.MC has a market cap of 203.76M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ORY.MC trades at $2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ORY.MC's P/E ratio is -37.57. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ORY.MC's ROE of -0.04%. Regarding short-term risk, ARGX.BR is more volatile compared to ORY.MC. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs GNFT.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, GNFT.PA has a market cap of 191.29M. Regarding current trading prices, ARGX.BR is priced at $488.70, while GNFT.PA trades at $3.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas GNFT.PA's P/E ratio is 128.07. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to GNFT.PA's ROE of +0.02%. Regarding short-term risk, ARGX.BR is more volatile compared to GNFT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ONWD.BR Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ONWD.BR has a market cap of 190.86M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ONWD.BR trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ONWD.BR's P/E ratio is -3.92. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ONWD.BR's ROE of -1.08%. Regarding short-term risk, ARGX.BR is more volatile compared to ONWD.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs IPH.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, IPH.PA has a market cap of 183.39M. Regarding current trading prices, ARGX.BR is priced at $488.70, while IPH.PA trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas IPH.PA's P/E ratio is -3.26. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to IPH.PA's ROE of -2.63%. Regarding short-term risk, ARGX.BR is more volatile compared to IPH.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs HYL.BR Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, HYL.BR has a market cap of 162.40M. Regarding current trading prices, ARGX.BR is priced at $488.70, while HYL.BR trades at $5.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas HYL.BR's P/E ratio is -25.22. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to HYL.BR's ROE of -0.19%. Regarding short-term risk, ARGX.BR is more volatile compared to HYL.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs NANO.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, NANO.PA has a market cap of 158.53M. Regarding current trading prices, ARGX.BR is priced at $488.70, while NANO.PA trades at $3.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas NANO.PA's P/E ratio is -2.34. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to NANO.PA's ROE of +0.77%. Regarding short-term risk, ARGX.BR is less volatile compared to NANO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs OSE.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, OSE.PA has a market cap of 135.74M. Regarding current trading prices, ARGX.BR is priced at $488.70, while OSE.PA trades at $6.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas OSE.PA's P/E ratio is 3.52. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to OSE.PA's ROE of +0.52%. Regarding short-term risk, ARGX.BR is more volatile compared to OSE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALSEN.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALSEN.PA has a market cap of 111.48M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALSEN.PA trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALSEN.PA's P/E ratio is -4.12. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALSEN.PA's ROE of -0.33%. Regarding short-term risk, ARGX.BR is less volatile compared to ALSEN.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALCLS.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALCLS.PA has a market cap of 96.03M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALCLS.PA trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALCLS.PA's P/E ratio is -3.70. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALCLS.PA's ROE of -0.29%. Regarding short-term risk, ARGX.BR is more volatile compared to ALCLS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ADOC.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ADOC.PA has a market cap of 87.66M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ADOC.PA trades at $4.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ADOC.PA's P/E ratio is -3.24. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ADOC.PA's ROE of +1.28%. Regarding short-term risk, ARGX.BR is less volatile compared to ADOC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs MAAT.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, MAAT.PA has a market cap of 83.15M. Regarding current trading prices, ARGX.BR is priced at $488.70, while MAAT.PA trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas MAAT.PA's P/E ratio is -2.35. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to MAAT.PA's ROE of -1.61%. Regarding short-term risk, ARGX.BR is less volatile compared to MAAT.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs TNG.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, TNG.PA has a market cap of 77.84M. Regarding current trading prices, ARGX.BR is priced at $488.70, while TNG.PA trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas TNG.PA's P/E ratio is -2.03. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to TNG.PA's ROE of -4.66%. Regarding short-term risk, ARGX.BR is more volatile compared to TNG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ERYP.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ERYP.PA has a market cap of 48.66M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ERYP.PA trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ERYP.PA's P/E ratio is -80.10. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ERYP.PA's ROE of -0.73%. Regarding short-term risk, ARGX.BR is more volatile compared to ERYP.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs VVY.AS Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, VVY.AS has a market cap of 45.83M. Regarding current trading prices, ARGX.BR is priced at $488.70, while VVY.AS trades at $1.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas VVY.AS's P/E ratio is -2.23. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to VVY.AS's ROE of -1.88%. Regarding short-term risk, ARGX.BR is more volatile compared to VVY.AS. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ABNX.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ABNX.PA has a market cap of 42.58M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ABNX.PA trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ABNX.PA's P/E ratio is -9.45. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ABNX.PA's ROE of -0.52%. Regarding short-term risk, ARGX.BR is more volatile compared to ABNX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs COX.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, COX.PA has a market cap of 29.04M. Regarding current trading prices, ARGX.BR is priced at $488.70, while COX.PA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas COX.PA's P/E ratio is -0.46. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to COX.PA's ROE of -0.43%. Regarding short-term risk, ARGX.BR is less volatile compared to COX.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALGEN.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALGEN.PA has a market cap of 28.29M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALGEN.PA trades at $3.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALGEN.PA's P/E ratio is 18.17. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALGEN.PA's ROE of +0.10%. Regarding short-term risk, ARGX.BR is more volatile compared to ALGEN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs FALG.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, FALG.PA has a market cap of 23.95M. Regarding current trading prices, ARGX.BR is priced at $488.70, while FALG.PA trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas FALG.PA's P/E ratio is -2.33. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to FALG.PA's ROE of -0.39%. Regarding short-term risk, ARGX.BR is less volatile compared to FALG.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs DMSIM.BR Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, DMSIM.BR has a market cap of 23.09M. Regarding current trading prices, ARGX.BR is priced at $488.70, while DMSIM.BR trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas DMSIM.BR's P/E ratio is 0.09. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to DMSIM.BR's ROE of -0.57%. Regarding short-term risk, ARGX.BR is less volatile compared to DMSIM.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs POXEL.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, POXEL.PA has a market cap of 21.64M. Regarding current trading prices, ARGX.BR is priced at $488.70, while POXEL.PA trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas POXEL.PA's P/E ratio is -1.01. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to POXEL.PA's ROE of +0.32%. Regarding short-term risk, ARGX.BR is less volatile compared to POXEL.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALDVI.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALDVI.PA has a market cap of 21.48M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALDVI.PA trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALDVI.PA's P/E ratio is -2.33. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALDVI.PA's ROE of +0.44%. Regarding short-term risk, ARGX.BR is less volatile compared to ALDVI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs CYAD.BR Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, CYAD.BR has a market cap of 18.64M. Regarding current trading prices, ARGX.BR is priced at $488.70, while CYAD.BR trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas CYAD.BR's P/E ratio is -0.33. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to CYAD.BR's ROE of +0.91%. Regarding short-term risk, ARGX.BR is less volatile compared to CYAD.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALVAL.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALVAL.PA has a market cap of 17.31M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALVAL.PA trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALVAL.PA's P/E ratio is -1.73. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALVAL.PA's ROE of -0.74%. Regarding short-term risk, ARGX.BR is more volatile compared to ALVAL.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALNFL.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALNFL.PA has a market cap of 17.11M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALNFL.PA trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALNFL.PA's P/E ratio is -8.01. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALNFL.PA's ROE of -1.27%. Regarding short-term risk, ARGX.BR is less volatile compared to ALNFL.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs AELIS.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, AELIS.PA has a market cap of 16.72M. Regarding current trading prices, ARGX.BR is priced at $488.70, while AELIS.PA trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas AELIS.PA's P/E ratio is -2.22. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to AELIS.PA's ROE of -0.74%. Regarding short-term risk, ARGX.BR is more volatile compared to AELIS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALPHE.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALPHE.PA has a market cap of 15.83M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALPHE.PA trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALPHE.PA's P/E ratio is -2.67. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALPHE.PA's ROE of -0.64%. Regarding short-term risk, ARGX.BR is more volatile compared to ALPHE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALPAT.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALPAT.PA has a market cap of 12.34M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALPAT.PA trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALPAT.PA's P/E ratio is 11.11. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALPAT.PA's ROE of +0.01%. Regarding short-term risk, ARGX.BR is more volatile compared to ALPAT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs BAI.AS Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, BAI.AS has a market cap of 11.25M. Regarding current trading prices, ARGX.BR is priced at $488.70, while BAI.AS trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas BAI.AS's P/E ratio is -0.13. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to BAI.AS's ROE of -0.51%. Regarding short-term risk, ARGX.BR is less volatile compared to BAI.AS. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALVET.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALVET.PA has a market cap of 10.02M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALVET.PA trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALVET.PA's P/E ratio is -0.17. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALVET.PA's ROE of -0.32%. Regarding short-term risk, ARGX.BR is less volatile compared to ALVET.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALVIO.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALVIO.PA has a market cap of 9.95M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALVIO.PA trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALVIO.PA's P/E ratio is -0.46. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALVIO.PA's ROE of -2.09%. Regarding short-term risk, ARGX.BR is more volatile compared to ALVIO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs APM.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, APM.PA has a market cap of 8.82M. Regarding current trading prices, ARGX.BR is priced at $488.70, while APM.PA trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas APM.PA's P/E ratio is -0.71. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to APM.PA's ROE of +0.08%. Regarding short-term risk, ARGX.BR is less volatile compared to APM.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALTME.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALTME.PA has a market cap of 6.93M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALTME.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALTME.PA's P/E ratio is -0.60. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALTME.PA's ROE of -8.99%. Regarding short-term risk, ARGX.BR is more volatile compared to ALTME.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALTHX.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALTHX.PA has a market cap of 5.08M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALTHX.PA trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALTHX.PA's P/E ratio is -3.89. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALTHX.PA's ROE of +7.08%. Regarding short-term risk, ARGX.BR is less volatile compared to ALTHX.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALQGC.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALQGC.PA has a market cap of 5.00M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALQGC.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALQGC.PA's P/E ratio is -0.09. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALQGC.PA's ROE of +14.01%. Regarding short-term risk, ARGX.BR is more volatile compared to ALQGC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs LYS.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, LYS.PA has a market cap of 4.95M. Regarding current trading prices, ARGX.BR is priced at $488.70, while LYS.PA trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas LYS.PA's P/E ratio is -0.64. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to LYS.PA's ROE of -11.30%. Regarding short-term risk, ARGX.BR is more volatile compared to LYS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALINT.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALINT.PA has a market cap of 3.97M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALINT.PA trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALINT.PA's P/E ratio is -15.00. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALINT.PA's ROE of -0.14%. Regarding short-term risk, ARGX.BR is more volatile compared to ALINT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALHYG.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALHYG.PA has a market cap of 3.95M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALHYG.PA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALHYG.PA's P/E ratio is -0.26. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALHYG.PA's ROE of -6.80%. Regarding short-term risk, ARGX.BR is less volatile compared to ALHYG.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALACT.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALACT.PA has a market cap of 3.94M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALACT.PA trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALACT.PA's P/E ratio is -0.22. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALACT.PA's ROE of +1.38%. Regarding short-term risk, ARGX.BR is more volatile compared to ALACT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALBPS.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALBPS.PA has a market cap of 3.45M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALBPS.PA trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALBPS.PA's P/E ratio is -0.04. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALBPS.PA's ROE of +1.88%. Regarding short-term risk, ARGX.BR is less volatile compared to ALBPS.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs GNRO.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, GNRO.PA has a market cap of 2.03M. Regarding current trading prices, ARGX.BR is priced at $488.70, while GNRO.PA trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas GNRO.PA's P/E ratio is -0.12. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to GNRO.PA's ROE of +2.39%. Regarding short-term risk, ARGX.BR is less volatile compared to GNRO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALMDP.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALMDP.PA has a market cap of 1.77M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALMDP.PA trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALMDP.PA's P/E ratio is -0.59. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALMDP.PA's ROE of +0.40%. Regarding short-term risk, ARGX.BR is less volatile compared to ALMDP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALDEI.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALDEI.PA has a market cap of 1.13M. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALDEI.PA trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALDEI.PA's P/E ratio is -0.11. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALDEI.PA's ROE of +0.61%. Regarding short-term risk, ARGX.BR is less volatile compared to ALDEI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs BIOS.BR Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, BIOS.BR has a market cap of 1.11M. Regarding current trading prices, ARGX.BR is priced at $488.70, while BIOS.BR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas BIOS.BR's P/E ratio is -0.04. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to BIOS.BR's ROE of +0.34%. Regarding short-term risk, ARGX.BR is less volatile compared to BIOS.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs OVXA.IR Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, OVXA.IR has a market cap of 856420.00. Regarding current trading prices, ARGX.BR is priced at $488.70, while OVXA.IR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas OVXA.IR's P/E ratio is -0.21. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to OVXA.IR's ROE of -0.00%. Regarding short-term risk, ARGX.BR is more volatile compared to OVXA.IR. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs OXUR.BR Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, OXUR.BR has a market cap of 321214.00. Regarding current trading prices, ARGX.BR is priced at $488.70, while OXUR.BR trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas OXUR.BR's P/E ratio is N/A. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to OXUR.BR's ROE of -0.01%. Regarding short-term risk, ARGX.BR is more volatile compared to OXUR.BR. This indicates potentially higher risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALNEV.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALNEV.PA has a market cap of 17346.00. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALNEV.PA trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALNEV.PA's P/E ratio is N/A. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALNEV.PA's ROE of -1.23%. Regarding short-term risk, ARGX.BR is less volatile compared to ALNEV.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.
ARGX.BR vs ALPHA.PA Comparison
ARGX.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ARGX.BR stands at 29.84B. In comparison, ALPHA.PA has a market cap of 1190.00. Regarding current trading prices, ARGX.BR is priced at $488.70, while ALPHA.PA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ARGX.BR currently has a P/E ratio of 43.44, whereas ALPHA.PA's P/E ratio is -0.00. In terms of profitability, ARGX.BR's ROE is +0.17%, compared to ALPHA.PA's ROE of +0.83%. Regarding short-term risk, ARGX.BR is less volatile compared to ALPHA.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ARGX.BR.